Navigation Links
Takeda to Acquire Inviragen, Inc.
Date:5/7/2013

eted Phase 1 clinical testing. Inviragen has also developed a recombinant vaccine candidate to protect against chikungunya, currently in preclinical development.

"The acquisition of Inviragen supports Takeda's overall research and development programs, long-term growth strategy and commitment to improve health through innovation and new technology," said Tadataka Yamada , M.D., Takeda's chief medical and scientific officer and member of the Takeda board of directors. "Coming less than a year after the acquisition of LigoCyte with the world's leading norovirus vaccine candidate, this illustrates Takeda's commitment to its global vaccine business and global public health."

Dengue is the most important mosquito-borne viral illness in the world, and is one of four World Health Organization (WHO) future vaccine priorities. It is estimated that about 400 million people worldwide are infected by the dengue virus each year, of which nearly 100 million develop clinical illness. Approximately 500,000 people are hospitalized and 20,000, mostly children, die from severe complications such as hemorrhagic fever. Currently there are only symptomatic treatments available for dengue and dengue hemorrhagic fever, and the only means of prevention is through mosquito control. The number of reported symptomatic dengue infections has increased 30-fold in the past 50 years, and the global footprint of dengue is expanding. HFMD epidemics occur annually throughout the Asia Pacific region, with millions of cases reported yearly since 2010. Chikungunya, which is a mosquito-transmitted virus, has produced epidemics in Africa, India, Asia and Europe. There are no specific treatments or cures for dengue, HFMD or chikungunya. Takeda will work with governments and international organizations to ensure that these vaccines reach
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda Responds to Verdict in Diabetes Drug Case
2. Takeda Launches New Subsidiary in Ecuador
3. Takeda lanza nueva subsidiaria en Ecuador
4. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
5. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
6. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
7. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
8. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
9. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
10. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
11. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015  The MEDevice San Diego Conference, ... an event dedicated to bringing medtech professionals together for ... topics affecting the industry today. This year,s conference will ... and opportunities facing today,s medtech professional in a fun, ... register for MEDevice San Diego, please visit: MEDeviceSD.com. ...
(Date:6/30/2015)... FREMONT, Calif. , June 30, 2015 ... and specialty medicine, continues to grow and add customers ... than 40% of the 62 CTSAs awarded by the ... clinical research information management. This is among the largest ... "Our presence in the CTSA community keeps growing ...
(Date:6/30/2015)... 30, 2015 Nortek Security & Control ... ) and a leader in the residential and ... it acquired mobile personal emergency response system (mPERS) ... Inc. Headquartered in ... mobile PERS products and cloud-based software platforms that ...
Breaking Medicine Technology:MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2Velos continues adding CTSA customers - 40% now use Velos products 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 4
... WORTH, Texas, Aug. 26 Healthpoint today announced,that ... the effectiveness of a,widely prescribed enzymatic debriding agent ... study was prompted, in part, by clinical reports,of ... healing,properties associated with Collagenase SANTYL(R) Ointment.(1,2), "Given ...
... Inc.,(Nasdaq: XTNT ) today announced that the positive ... in the most recent issue of the,peer-reviewed journal, EuroIntervention. ... Stella, M.D., of University Medical Center Utrecht, Utrecht,The Netherlands ... clinical,sites across Europe., The one-year CUSTOM II trial, ...
Cached Medicine Technology:Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4
(Date:6/30/2015)... ... ... Institute of Personal Injury Attorneys (AIOPIA) awarded JTB Law Group, LLC as a firm, and ... As of July 1, 2015, the firm and Mr. Brown personally have been recognized ... The award is a culmination of the hard work, long hours, and excellent results the ...
(Date:6/30/2015)... ... 30, 2015 , ... The board certified otolaryngologists at Clear ... to inform potential sinus surgery patients about ear, nose, and throat (ENT) ailments ... a wide variety of ENT issues including hearing loss, ear infections, dizziness, sleep ...
(Date:6/30/2015)... ... 2015 , ... According to research by European archeologists that was recently discussed ... four hundred thousand years ago likely knew that eating a balanced diet and limiting ... ancient dental plaque, researchers were able to find evidence of plant fibers, in addition ...
(Date:6/30/2015)... ... June 30, 2015 , ... The Blue Cross and Blue Shield of ... across the state. The projects improve community health by focusing on the social and ... many are renewable for a second year in 2016 based on progress in 2015. ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... UHMS approved 40-hour Introduction to Hyperbaric Medicine Course. Clinicians from WCA partnering hospitals ... hyperbaric medicine curriculum. , Wound care and hyperbaric medicine education and training ...
Breaking Medicine News(10 mins):Health News:JTB Law Group, LLC Recognized as a Top 10 Best Law Firm by AIOPIA 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 3Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3
... rates in South, Southwest; lowest rates in Northeast, government reports ... rate in the United States increased in 26 of the ... country, according to a new government report. , Back ... Prevention reported that the teen birth rate for the entire ...
... recognized inpatient treatment center, is pleased to announce its plans ... is just a few of the ways Seabrook ... possible and that treatment works. Seabrook House,s vision is to ... to educate the public at large in an effort to ...
... Top Government Officials Will Explain Regulatory Plans for Cutting-Edge Technology ... , DC . WASHINGTON, Jan. 7 ... goods last year. By 2014, the market will grow to ... and therapeutics will be sold--up from more than $3 billion ...
... more and more Michigan residents,losing employer-sponsored health coverage, the ... To ease the burden, the Blue Cross,Blue Shield ... in matching,funds for projects that improve health care access ... "Fundable projects for the uninsured include creative and novel ...
... teenage boys don,t seem to be as susceptible, study suggests ... spend more than two hours of "screen time" a day ... to be physically fit, a new Australian study finds. , ... more likely to be able to "sit and be fit," ...
... COLUMBIA, Mo. There is no cure for spinal ... weakening of muscles and is the leading genetic cause ... discovered a new therapeutic target that improves deteriorating skeletal ... muscle strength, improved gross motor skills and increased the ...
Cached Medicine News:Health News:Teen Birth Rate Up in 26 States in 2006 2Health News:Seabrook House Embraces the New Year with New Programs 2Health News:Seabrook House Embraces the New Year with New Programs 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 2Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 4Health News:$1 Million Available to Help Michigan's Uninsured Receive Care 2Health News:More 'Screen Time' Linked to Poor Fitness in Girls 2Health News:Researchers discover target that could ease spinal muscular atrophy symptoms 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: